Home > Financial Ratios > THEMIS MEDICARE

THEMIS MEDICARE
Core EBITDA Growth

    Back to All Ratios
THEMIS MEDICARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for THEMIS MEDICARE
Please provide your vote to see the results

THEMIS MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.52-28.74-22.7392.3735.77

What is the latest Core EBITDA Growth ratio of THEMIS MEDICARE ?

The latest Core EBITDA Growth ratio of THEMIS MEDICARE is -4.52 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-4.52
Mar2024-28.74
Mar2023-22.73
Mar202292.37
Mar202135.77

How is Core EBITDA Growth of THEMIS MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.52
Negative
Mar2024 -28.74
Negative
Mar2023 -22.73
Negative
Mar2022 92.37
158.23
Mar2021 35.77 -

Other Financial Ratios of THEMIS MEDICARE


Compare Core EBITDA Growth ratio of peers of THEMIS MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THEMIS MEDICARE ₹836.2 Cr 6.5% 17.1% -29.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -1.4% -6.2% -1.6% Stock Analytics
DIVIS LABORATORIES ₹166,939.0 Cr -0.1% 2.3% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,109.0 Cr -1.8% -4.9% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,578.0 Cr -0.4% -6% 5.3% Stock Analytics
CIPLA ₹99,761.1 Cr 0.4% -2.6% -17.6% Stock Analytics


THEMIS MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THEMIS MEDICARE

6.5%

17.1%

-29.4%

SENSEX

0.5%

3.2%

2.3%


You may also like the below Video Courses